In agreement with these observations, we have proven that intratracheal transplantation of EPO-BM-MSCs is more efficient for diminishing lung inflammation, airway reactivity, and Th2 inflammatory cytokine secretion than BM-MSCs in OVA-induced asthma mice. Here, EPO is linked to asthma.